Report
Valens Research

STZ - Embedded Expectations Analysis - 2019 04 18

Constellation Brands, Inc. (STZ:USA) currently trades near recent highs relative to UAFRS-based (Uniform) Earnings, with a 28.3x Uniform P/E. However, even at these levels, the market has bearish expectations for the firm, but management is confident in the launch of Corona Familiar draft and Alera, their Mexicali capacity expansion project, and their Canopy guidance.

Specifically, management is confident in the growth potential of their Corona Familiar line, and in the launch of Alera in test markets. Moreover, they are confident in their Mexicali capacity expansion project, their ability to achieve run rate guidance in Canopy Growth, and their wine and spirits business. Furthermore, they are confident in their ability to meet EPS guidance, and in their international medical marijuana revenue.
Underlying
Constellation Brands Inc. Class A

Constellation Brands is an international beverage alcohol company. The company is a producer and marketer of beer, wine and spirits with operations in the U.S., Mexico, New Zealand, Italy and Canada. The company has two segments: Beer, in which the company is engaged in the U.S. beer market that includes the imported, craft, domestic super premium, and alternative beverage alcohol categories and it has the right to import, market and sell these Mexican beer brands in the U.S.; and Wine and Spirits, in which its wine portfolio is supported by grapes purchased from independent growers, primarily in the U.S., New Zealand and Chile, and vineyard holdings in the U.S., New Zealand and Italy.

Provider
Valens Research
Valens Research

In 2009, just as the dust was settling from the last major equity and credit market crises, we launched a boutique research firm with the intention of breaking Wall Street’s biases and broken incentives:

  • GAAP and IFRS have failed to provide rules for reliable financial statement reporting
  • Stock analyst recommendations are not grounded in disciplined financial analysis
  • Credit agencies have been set up to grossly fail in their responsibilities to investors and the public markets
  • Utter lack of willingness of major research firms to employ the the most advanced forensic analysis available

We sought to provide investors and company analysts with a source of information that changed all that.
Many years later, our business model remains because little has changed on Wall Street.

  • Corporate credit ratings remain years behind the fundamental underpinnings of company performance
  • Stock analysts continue to make recommendations with deeply inherent biases
  • Research firms have failed to break down the walls between credit, equity, and macroeconomic research
  • The governing accounting bodies have created more leeway for mis-estimates and mis-classifications as financials have become unwieldy and overwhelming

The integrity of Valens Research is founded in our disciplined processes and analytics. No “star” analysts. No corporate advisory relationships. No-nonsense opinions and recommendations.

Analysts
Valens Research

Other Reports on these Companies
Other Reports from Valens Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch